Efficacy and Safety of Alirocumab in Japanese Patients with Diabetes Mellitus: Post-hoc Subanalysis of ODYSSEY Japan

類似資料

• Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
  著者:: Nam, Chang-Wook, 等
  出版事項: (2019)
• Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale
  著者:: Teramoto, Tamio, 等
  出版事項: (2017)
• Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials
  著者:: Leiter, L. A., 等
  出版事項: (2017)
• Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials
  著者:: Leiter, L. A., 等
  出版事項: (2018)
• Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
  著者:: Kastelein, John J. P., 等
  出版事項: (2014)